Health
Study shows persisting cognitive benefits of common Alzheimer’s treatment – News-Medical.net
Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer’s disease, but their effects on cognition have been debated and few studies…
Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer’s disease, but their effects on cognition have been debated and few studies have investigated their long-term effects. A new study involving researchers from Karolinska Institutet in Sweden and published in the journal Neurology shows persisting cognitive benefits and reduced mortality for up to five years after diagnosis.
Alzheimer’s disease is a cognitive brain disease that affects millions of patients around…
-
Noosa News19 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News20 hours agoMotorcyclist dies in crash with truck
-
Noosa News20 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
Noosa News18 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush